<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00420134</url>
  </required_header>
  <id_info>
    <org_study_id>348</org_study_id>
    <nct_id>NCT00420134</nct_id>
  </id_info>
  <brief_title>Improvement of Liver Function in Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection:a Phase I-II Clinical Trial</brief_title>
  <official_title>A Phase One/Two Clinical Trial on the Use of Autograft Mesenchymal Stem Cells Differentiated Into Progenitor of Hepatocytes for the Salvage Treatment of Patients With End-stage Liver Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tarbiat Modarres University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shahid Beheshti University of Medical Sciences</source>
  <brief_summary>
    <textblock>
      The methods for separation of mesenchymal stem cell were established in 2001. These cells can
      differentiate to osteocytes, hepatocytes, chondrocytes, myocytes and etc,. In this study the
      investigators try to separate mesenchymal stem cell from end stage liver disease, then these
      cells will be differentiated to progenitor of hepatocytes, finally , the investigators
      injected these cells into portal vein under ultrasound guide. The investigators determine the
      effects of injected cells in reestablishment of liver function.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2006</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Liver function test</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>MELD score</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cirrhosis mortality after 6 months</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Liver Failure</condition>
  <condition>Cirrhosis</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>injection of progenitor of hepatocyte drived from Mesenchymal stem cell</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  MELD score of at least 10

          -  Patent portal vein on color Doppler examination of the liver

          -  Normal alpha-feto protein serum levels

          -  Age more than 18

          -  Filling inform consent by patients and first degree family members

        Exclusion criteria:

          -  Any evidence of hepatocellular carcinoma on liver ultrasound studies

          -  Patients want to exclude from study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammad Reza Zali, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Research center of Gastroenterology and Liver Disease</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pedram Kharaziha, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Center for Gastroenterology and Liver Diseases</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Center for Gastroenterology and Liver Diseases</name>
      <address>
        <city>Tehran</city>
        <zip>1985711151</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research center of Gastroenterology and Liver Disease</name>
      <address>
        <city>Tehran</city>
        <zip>1985711151</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2007</study_first_submitted>
  <study_first_submitted_qc>January 8, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2007</study_first_posted>
  <last_update_submitted>September 15, 2009</last_update_submitted>
  <last_update_submitted_qc>September 15, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 17, 2009</last_update_posted>
  <keyword>mesenchymal stem cell</keyword>
  <keyword>end stage liver disease</keyword>
  <keyword>Cirrhosis</keyword>
  <keyword>stem cell therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Liver Failure</mesh_term>
    <mesh_term>End Stage Liver Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

